MedPageToday -- ATLANTA -- Disease progression is less likely in patients with rheumatoid arthritis (RA) who haven’t responded to methotrexate alone if this disease-modifying drug is continued when treatment with the biologic drug etanercept (Enbrel) is initiated, according to research presented here.
